North America Cancer Diagnostics Market is Projected to Reach USD 17.72 Bn by 2024 from USD 7.59 Bn in 2016
Reports Web announces the release of market assessment report on “North America Cancer Diagnostics Market Analysis and Forecast to 2024". The report is segmented into several key Regions, with production, consumption, revenue and market share.
(EMAILWIRE.COM, November 18, 2017 ) North America cancer diagnostics market is projected to reach USD 17.72 billion by 2024 from USD 7.59 billion in 2016, at a CAGR of 11.2% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America. These factors increase the demand for cancer diagnostic products.
Based on geography, the North America cancer diagnostics market is segmented into 5 geographical regions, such as,
U.S.,
Mexico,
Canada,
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW00011194793/sample
North America cancer diagnostics market competition by top players including-
GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as
Hologic Inc.,
Becton, Dickinson & Company.
Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as
Roche Diagnostics,
Abbott Laboratories, Inc.
QIAGEN.
Inquiry for This Report@ http://www.reportsweb.com/inquiry&RW00011194793/buying
The North America cancer diagnostics market is segmented on the basis of technology, application and geography.
On the basis of technology, North America cancer diagnostics market is segmented into 2 types, namely platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 69.4%
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others.
Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), mammography and ultrasound.
Buy This Report@ http://www.reportsweb.com/buy&RW00011194793/buy/2500
On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America. These factors increase the demand for cancer diagnostic products.
Based on geography, the North America cancer diagnostics market is segmented into 5 geographical regions, such as,
U.S.,
Mexico,
Canada,
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW00011194793/sample
North America cancer diagnostics market competition by top players including-
GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as
Hologic Inc.,
Becton, Dickinson & Company.
Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as
Roche Diagnostics,
Abbott Laboratories, Inc.
QIAGEN.
Inquiry for This Report@ http://www.reportsweb.com/inquiry&RW00011194793/buying
The North America cancer diagnostics market is segmented on the basis of technology, application and geography.
On the basis of technology, North America cancer diagnostics market is segmented into 2 types, namely platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 69.4%
Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others.
Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), mammography and ultrasound.
Buy This Report@ http://www.reportsweb.com/buy&RW00011194793/buy/2500
On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results